Wh. Newman et al., TOLERANCE TO NITROGLYCERIN IN VASCULAR SMOOTH-MUSCLE CELLS IS NOT AFFECTED BY THE LEVEL OF INTRACELLULAR GLUTATHIONE OR L-CYSTEINE, Anesthesia and analgesia, 81(6), 1995, pp. 1229-1234
A major hypothesis for the mechanism of tolerance to nitroglycerin (NT
G) is that continued use causes a decrease in thiol donors within the
vascular smooth muscle cell that are essential for the effect of NTG.
We tested this idea directly in the target cell. NTG tolerance, measur
ed as reduced formation of intracellular cyclic guanosine monophosphat
e (cGMP), was induced in pig coronary smooth muscle cells. The consequ
ence of altering intracellular levels of the thiol donors, glutathione
(GSH) and L-cysteine (L-cys), was determined. Incubating cells with 1
00 mu M NTG for 1 h caused an 83% reduction in cGMP formation in respo
nse to acute readministration of 200 mu M NTG for 2 min but was not as
sociated with a reduction in intracellular GSH or L-cys. This result w
as not altered when intracellular GSH levels were increased threefold
by including 1 mM GSH in the incubation buffer. Also, recovery from to
lerance was not affected by supplementation with GSH. Further, the res
ponse of cGMP to NTG was not altered by inhibiting the synthesis of GS
H and lowering intracellular levels of GSH by 77%. Similar findings we
re made with supplemental L-cys or N-acetyl-L-cysteine. These results
do not support the hypothesis that tolerance to NTG is the result of a
reduction of the thiol donors GSH and L-cys within vascular smooth mu
scle cells.